| Source: |
| Type: |
| Gut microbiome may affect responses to numerous forms of cancer therapy. The gut microbiota plays a multifaceted role in cancer biology, influencing tumor development, progression, and patient prognosis. Dysbiosis and specific microbial populations have been linked to various cancers, with implications for patient outcomes. While the relationship between gut microbiota and cancer prognosis is an active area of research, it holds promise for the development of microbiome-based biomarkers and therapeutic strategies in oncology. |
| 5859- | CAP, | Are We Ready to Recommend Capsaicin for Disorders Other Than Neuropathic Pain? |
| - | Review, | Var, | NA |
| 5858- | CAP, | Capsaicin as a Microbiome Modulator: Metabolic Interactions and Implications for Host Health |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 1265- | CAP, | Capsaicin shapes gut microbiota and pre-metastatic niche to facilitate cancer metastasis to liver |
| - | in-vivo, | CRC, | NA |
| 5933- | CAR, | Protective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model |
| - | in-vivo, | IBD, | NA |
| 5932- | CAR, | Carvacrol attenuates mucosal barrier impairment and tumorigenesis by regulating gut microbiome |
| - | in-vivo, | IBD, | NA | - | in-vivo, | Park, | NA |
| 9142- | CC, | immuno, | Combination nivolumab and ipilimumab with and without camu camu in first-line treatment of metastatic renal cell carcinoma (mRCC) |
| - | Trial, | RCC, | NA |
| 9139- | CC, | Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice |
| - | in-vivo, | Obesity, | NA |
| 9137- | CC, | Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial |
| - | Trial, | LiverDam, | NA |
| 9136- | CC, | immuno, | Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu Prebiotic |
| - | Case Report, | Melanoma, | NA |
| 9135- | CC, | A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota |
| - | in-vivo, | Var, | NA |
| 9134- | CC, | Camu camu plus nivolumab/ipilimumab (N/I) as first-line therapy for metastatic renal cell carcinoma (mRCC): A randomized phase I trial |
| - | Trial, | RCC, | NA |
| 6650- | Cen, | Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review |
| - | Review, | AD, | NA |
| 6022- | CGA, | Chlorogenic Acid: Recent Advances on Its Dual Role as a Food Additive and a Nutraceutical against Metabolic Syndrome |
| - | Review, | Nor, | NA |
| 6016- | CGA, | Coffee Chlorogenic Acids Incorporation for Bioactivity Enhancement of Foods: A Review |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Diabetic, | NA |
| 6011- | CGA, | Chlorogenic Acid’s Role in Metabolic Health: Mechanisms and Therapeutic Potential |
| - | Review, | Nor, | NA |
| 6045- | CGA, | SeNPs, | A Flower-like Brain Targeted Selenium Nanocluster Lowers the Chlorogenic Acid Dose for Ameliorating Cognitive Impairment in APP/PS1 Mice |
| - | in-vivo, | AD, | NA |
| 6023- | CGA, | Pharmacological advances of the chlorogenic acids family: current insights and future research directions |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | IBD, | NA |
| 4487- | Chit, | PreB, | Unravelling the Role of Chitin and Chitosan in Prebiotic Activity and Correlation With Cancer: A Narrative Review |
| - | Review, | Var, | NA |
| 6079- | CHL, | Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice |
| - | in-vivo, | Nor, | NA |
| 6094- | CHOC, | Impact of Cocoa Products Intake on Plasma and Urine Metabolites: A Review of Targeted and Non-Targeted Studies in Humans |
| - | Human, | Nor, | NA |
| 6101- | Chol, | Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-N-Oxide Response in Healthy Men |
| - | Human, | Nor, | NA |
| 3890- | Cin, | The Therapeutic Roles of Cinnamaldehyde against Cardiovascular Diseases |
| - | Review, | CardioV, | NA |
| 6145- | Cin, | Cinnamaldehyde microcapsules enhance bioavailability and regulate intestinal flora in mice |
| - | in-vivo, | Nor, | NA |
| 6164- | Cin, | Advances in pharmacological effects and mechanism of action of cinnamaldehyde |
| - | Review, | Var, | NA | - | Review, | PSA, | NA |
| 6169- | Cin, | Unlocking the Power of Cinnamon: A Detailed Review of Cinnamon Therapeutic Effects in Chronic Disease Management |
| - | Review, | Var, | NA | - | Review, | Diabetic, | NA | - | Review, | AD, | NA | - | Review, | IBD, | NA |
| 5798- | CRMs, | Caloric restriction mimetics improve gut microbiota: a promising neurotherapeutics approach for managing age-related neurodegenerative disorders |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 3794- | CUR, | Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities |
| - | Review, | AD, | NA |
| 4673- | CUR, | Curcumin and colorectal cancer: An update and current perspective on this natural medicine |
| - | Review, | CRC, | NA |
| 6216- | CUR, | Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials |
| - | Review, | Var, | NA |
| 6223- | CUR, | Curcumin Rewires the Tumor Metabolic Landscape: Mechanisms and Clinical Prospects |
| - | Review, | Var, | NA |
| 9037- | CV, | SP, | Chlorella and Arthrospira (Spirulina) as Multi-Pathway Biological Response Modulators: Molecular Mechanisms, Signaling Pathways and Clinical Evidence |
| - | Review, | Nor, | NA |
| 6666- | DFE, | The impact of date palm fruits and their component polyphenols, on gut microbial ecology, bacterial metabolites and colon cancer cell proliferation |
| - | in-vitro, | Colon, | Caco-2 |
| 6663- | DFE, | Nutraceuticals of Phoenix dactylifera L.: Physicochemistry, Nutritional Value and Therapeutic Potential |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 6710- | dietF, | The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods |
| - | Review, | Nor, | NA |
| 6717- | dietF, | Fermented foods consumption, all-cause, and cause-specific mortality: a meta-analysis of prospective cohort studies |
| - | Review, | CardioV, | NA |
| 6711- | dietF, | Gut-microbiota-targeted diets modulate human immune status |
| - | Trial, | Nor, | NA |
| 6715- | dietF, | Are Fermented Foods Effective against Inflammatory Diseases? |
| - | Review, | Nor, | NA |
| 6716- | dietF, | Current Research in Fermented Foods: Bridging Tradition and Science |
| - | Review, | Nor, | NA |
| 1850- | dietFMD, | Fasting-mimicking diet remodels gut microbiota and suppresses colorectal cancer progression |
| - | in-vivo, | CRC, | NA |
| 1856- | dietFMD, | immuno, | Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A Review |
| - | Review, | Var, | NA |
| 1863- | dietFMD, | Chemo, | Effect of fasting on cancer: A narrative review of scientific evidence |
| - | Review, | Var, | NA |
| 1844- | dietFMD, | Unlocking the Potential: Caloric Restriction, Caloric Restriction Mimetics, and Their Impact on Cancer Prevention and Treatment |
| - | Review, | Var, | NA |
| 2272- | dietMet, | Methionine restriction - Association with redox homeostasis and implications on aging and diseases |
| - | Review, | Nor, | NA |
| 1894- | dietMet, | Long term methionine restriction: Influence on gut microbiome and metabolic characteristics |
| - | in-vivo, | Nor, | NA |
| 8849- | DIM, | I3C, | Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3'-Diindolylmethane |
| - | Review, | Var, | NA |
| 8844- | DIM, | I3C, | Unveiling the Multifaceted Pharmacological Actions of Indole-3-Carbinol and Diindolylmethane: A Comprehensive Review |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 6363- | DRE, | Therapeutic Potential of Dandelion (Taraxacum officinale) Root Extract in Colon Cancer: A Comprehensive Review |
| - | in-vitro, | CRC, | NA |
| 6804- | EA, | Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status |
| - | Human, | Nor, | NA |
| 6783- | EGCG, | Absorption, metabolism, bioactivity, and biotransformation of epigallocatechin gallate |
| - | Review, | Nor, | NA |
| 6784- | EGCG, | Dietary (−)-Epigallocatechin Gallate (EGCG): State-of-the-Art Advances in Bioactivities, Bioavailability Enhancement Strategies, and Applications in Nutrition and Health |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:350 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid